What to do for prostate cancer patients with a rising PSA?—a survey of Australian practice
- 15 March 2003
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 55 (4) , 986-991
- https://doi.org/10.1016/s0360-3016(02)04213-x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 2001
- The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: a survey of practice patterns of urologists and radiation oncologists in the United StatesUrology, 2001
- LONG-TERM BIOCHEMICAL DISEASE-FREE AND CANCER-SPECIFIC SURVIVAL FOLLOWING ANATOMIC RADICAL RETROPUBIC PROSTATECTOMYUrologic Clinics of North America, 2001
- Preliminary Results of a Randomized Radiotherapy Dose-Escalation Study Comparing 70 Gy With 78 Gy for Prostate CancerJournal of Clinical Oncology, 2000
- PATTERNS OF TREATMENT OF PATIENTS WITH PROSTATE CANCER INITIALLY MANAGED WITH SURVEILLANCE: RESULTS FROM THE CaPSURE DATABASEJournal of Urology, 2000
- Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate CancerNew England Journal of Medicine, 1999
- Natural History of Progression After PSA Elevation Following Radical ProstatectomyJAMA, 1999
- Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancerRadiotherapy and Oncology, 1997
- Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trialBritish Journal of Urology, 1997
- Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate CancerJournal of Urology, 1994